Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 5 February 2008
Vol. 1, Issue 5, p. pe6
[DOI: 10.1126/stke.15pe6]

PERSPECTIVES

Metabotropic Glutamate Receptors and Fragile X Mental Retardation Protein: Partners in Translational Regulation at the Synapse

Jennifer A. Ronesi1 and Kimberly M. Huber1*

1Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Abstract: Fragile X syndrome (FXS) mental retardation is caused by loss-of-function mutations in an RNA-binding protein, fragile X mental retardation protein (FMRP). Previous studies in patients or animal models of FXS have identified alterations in dendritic spine structure, as well as synaptic plasticity induced by metabotropic glutamate receptors (mGluRs). The translation of multiple messenger RNA (mRNA) targets of FMRP is regulated by mGluRs at synapses. Here, we incorporate data from several studies into a working model of how FMRP regulates mGluR-stimulated protein synthesis and, in turn, regulates protein synthesis–dependent synaptic plasticity. Understanding the complex functions of FMRP at the synapse will lead to a better understanding of the neurobiological underpinnings of mental retardation.

*Corresponding author. Department of Neuroscience, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, NA4.118, Dallas, TX 75390–9011, USA; e-mail, kimberly.huber{at}utsouthwestern.edu

Citation: J. A. Ronesi, K. M. Huber, Metabotropic Glutamate Receptors and Fragile X Mental Retardation Protein: Partners in Translational Regulation at the Synapse. Sci. Signal. 1, pe6 (2008).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse.
H. Higashimori, L. Morel, J. Huth, L. Lindemann, C. Dulla, A. Taylor, M. Freeman, and Y. Yang (2013)
Hum. Mol. Genet. 22, 2041-2054
   Abstract »    Full Text »    PDF »
Learning and Memory Deficits Consequent to Reduction of the Fragile X Mental Retardation Protein Result from Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila.
A. K. Kanellopoulos, O. Semelidou, A. G. Kotini, M. Anezaki, and E. M. C. Skoulakis (2012)
J. Neurosci. 32, 13111-13124
   Abstract »    Full Text »    PDF »
Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function.
H. S. Bateup, K. T. Takasaki, J. L. Saulnier, C. L. Denefrio, and B. L. Sabatini (2011)
J. Neurosci. 31, 8862-8869
   Abstract »    Full Text »    PDF »
Parents' Decisions to Screen Newborns for FMR1 Gene Expansions in a Pilot Research Project.
D. Skinner, S. Choudhury, J. Sideris, S. Guarda, A. Buansi, M. Roche, C. Powell, and D. B. Bailey Jr (2011)
Pediatrics 127, e1455-e1463
   Abstract »    Full Text »    PDF »
Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome.
C. Gross, M. Nakamoto, X. Yao, C.-B. Chan, S. Y. Yim, K. Ye, S. T. Warren, and G. J. Bassell (2010)
J. Neurosci. 30, 10624-10638
   Abstract »    Full Text »    PDF »
Roles of Fragile X Mental Retardation Protein in Dopaminergic Stimulation-induced Synapse-associated Protein Synthesis and Subsequent {alpha}-Amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) Receptor Internalization.
H. Wang, S. S. Kim, and M. Zhuo (2010)
J. Biol. Chem. 285, 21888-21901
   Abstract »    Full Text »    PDF »
Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome.
A. Suvrathan, C. A. Hoeffer, H. Wong, E. Klann, and S. Chattarji (2010)
PNAS 107, 11591-11596
   Abstract »    Full Text »    PDF »
Delayed Stabilization of Dendritic Spines in Fragile X Mice.
A. Cruz-Martin, M. Crespo, and C. Portera-Cailliau (2010)
J. Neurosci. 30, 7793-7803
   Abstract »    Full Text »    PDF »
Dendritic mRNA Targeting of Jacob and N-Methyl-D-aspartate-induced Nuclear Translocation after Calpain-mediated Proteolysis.
S. Kindler, D. C. Dieterich, J. Schutt, J. Sahin, A. Karpova, M. Mikhaylova, C. Schob, E. D. Gundelfinger, H.-J. Kreienkamp, and M. R. Kreutz (2009)
J. Biol. Chem. 284, 25431-25440
   Abstract »    Full Text »    PDF »
No Change in the Age of Diagnosis for Fragile X Syndrome: Findings From a National Parent Survey.
D. B. Bailey Jr, M. Raspa, E. Bishop, and D. Holiday (2009)
Pediatrics 124, 527-533
   Abstract »    Full Text »    PDF »
Fragile X mental retardation protein interactions with the microtubule associated protein 1B RNA.
L. Menon, S. A. Mader, and M.-R. Mihailescu (2008)
RNA 14, 1644-1655
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882